Return of gene therapy: How to make the treatment safer

At the Wyss Institute for Biologically Inspired Engineering at Harvard University in Boston, Massachusetts, viral immunologist Ying Kai Chan is trying to develop safer AAV vectors. The risks increased when researchers used larger amounts of AAV, he told the conference: “I’m a big fan of reducing the dose.” But this may require the development of […]